Skip to main content
Log in

Solid Lipid Nanoparticles as Effective Reservoir Systems for Long-Term Preservation of Multidose Formulations

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Cosmetic multidose preparations, as well as pharmaceutical ones, are at risk of contamination by microorganisms, due to their high water content. Besides the risk of contamination during manufacturing, multidose cosmetic preparations may be contaminated by consumers during their use. In this paper, the results of the utilization of nanoparticles as reservoir systems of parabens, the most used class of preservatives, were reported. Two different systems, solid lipid nanoparticles (SLN) made of pure precirol and nanostructured lipid carriers (NLC) made of precirol and almond oil, containing three parabens as single molecules or as a mixture, were prepared and tested. All the systems were characterized for size, polydispersion index, zeta potential and encapsulation efficiency. Release experiments, carried out in steady state and sink conditions, allowed to evidence that both SLN and NLC were able to act as reservoir systems. The antimicrobial activity of the systems was tested against Candida albicans ATCC 10231 with repeat insult tests. The results of the release experiments and the antimicrobial tests showed very low water concentration of parabens still maintaining their antimicrobial activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

REFERENCES

  1. Lundov MD, Moesby L, Zachariae C, Johansen JD. Contamination versus preservation of cosmetics: a review legislation, usage, infections and contact allergy. Contact Dermatitis. 2009;60:70–8.

    Article  PubMed  Google Scholar 

  2. Tsai TF, Lee MR. Determination of antioxidants and preservatives in cosmetics by SPME combined with GC-MS. Chromatographia. 2008;67:425–31.

    Article  CAS  Google Scholar 

  3. Rastogi SC. Analytical control of preservatives labeling on skin creams. Contact Dermatitis. 2000;43:339–43.

    Article  CAS  PubMed  Google Scholar 

  4. EC Regulation N. 1223/2009 of the European Parliament and of the Council COUNCIL on cosmetic products. 2009. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:EN:PDF.

  5. Abrutyn ES. Optimizing formula preservation. Cosmet Toiletries. 2010;125:24–8.

    Google Scholar 

  6. Tsolis P, Schnittger S. Formula troubleshooting—preservation. Cosmet Toiletries. 2011;139:332–4.

    Google Scholar 

  7. Rastogi SC, Schouten A, de Kruijf W. Contents of methyl, ethyl, propyl, buthyl and benzylparaben in cosmetic products. Contact Dermatitis. 1995;32:28–30.

    Article  CAS  PubMed  Google Scholar 

  8. US Food and Drug Administration. Federal Food, Drug and Cosmetic Act. Food allergen labeling and consumers protection act, Public Law. 2004;108–282.

  9. Sakazaki F, Ueno H, Nagase H, Nakamuro K. p-Hydroxyl benzoate esters enhances mouse contact hypersensitivity. J Health Sci. 2009;55:560–6.

    Article  CAS  Google Scholar 

  10. Mehenert W, Mäder K. Solid lipid nanoparticles. Production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–96.

    Article  Google Scholar 

  11. Müller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery a review of the state of art. Eur J Pharm Biopharm. 2000;50:161–77.

    Article  PubMed  Google Scholar 

  12. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructurated lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131–55.

    Article  PubMed  Google Scholar 

  13. Ahlin P, Kristl J, Smid-Koar J. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersion. Acta Pharm. 1998;48:257–67.

    Google Scholar 

  14. Paolicelli P, Cerreto F, Cesa S, Feeney M, Corrente F, Marianecci C, et al. Influence of the formulation components on the properties of the system SLN-hydrogel for the controller release of drugs. J Microencapsul. 2008;12:1–10.

    Google Scholar 

  15. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal sceptibility testing of yeasts. Approved Standard-Third Edition M27-A3. Wayne: CLSI; 2008.

    Google Scholar 

  16. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; Informational Supplement M27-S3. Wayne: CLSI; 2008.

    Google Scholar 

  17. European Pharmacopoeia 6.0. European Pharmacopoeia 6.0. General Texts; 5.1.3. Efficacy of antimicrobial preservation. Directorate for the quality of Medicines and Health Care Council of Europe, Strasbourg, France; 2007. 528–529.

  18. European Pharmacopoeia 6.0. European Pharmacopoeia 6.0. Methods of analysis; 2.6.12. Microbiological examination of non-sterile products: total viable counts. Directorate for the quality of Medicines and Health Care Council of Europe, Strasbourg, France. 2007. 4769–4773.

  19. Travassos AR, Claes L, Boey L, Drieghe J, Goossens A. Non-fragrance allergens in specific cosmetic products. Contact Dermatitis. 2011;65:276–85.

    Article  CAS  PubMed  Google Scholar 

  20. Rougier A, Rallis M, Krien, Lotte C. In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning. Arch Dermatol Res. 1990;282:498–505.

    Article  CAS  PubMed  Google Scholar 

Download references

ACKNOWLEDGMENTS

This work was granted by MIUR (Ministero dell’Istruzione, dell’Università e della Ricerca).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Felice Cerreto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cerreto, F., Paolicelli, P., Cesa, S. et al. Solid Lipid Nanoparticles as Effective Reservoir Systems for Long-Term Preservation of Multidose Formulations. AAPS PharmSciTech 14, 847–853 (2013). https://doi.org/10.1208/s12249-013-9972-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-013-9972-y

KEY WORDS

Navigation